Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Purdon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advanced Emergency Nursing Journal|July 30, 2019
Choosing the Correct "-ase" in Acute Ischemic Stroke: Alteplase, Tenecteplase, and ReteplaseGeorge M Dillon, Stacie Stevens, Wendy L Dusenbury, et al.
Journal of Clinical Pharmacology|October 24, 2022
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic StrokeFei Tang, Jurgen Langenhorst, Steve Dang, et al.
Expert Opinion on Drug Safety|February 5, 2019
Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplaseKatleen Wyatt Chester, Megan Corrigan, J Megan Schoeffler, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 24, 2018
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and designSharon D Yeatts, Joseph P Broderick, Anjan Chatterjee, et al.
Stroke|September 9, 2021
Thrombolysis in Mild Stroke: A Comparative Analysis of the PRISMS and MaRISS StudiesNegar Asdaghi, Jose G Romano, Hannah Gardener, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 9, 2022
A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and designGregory W Albers, Bruce Cv Campbell, Maarten G Lansberg, et al.
JAMA|July 13, 2018
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical TrialPooja Khatri, Dawn O Kleindorfer, Thomas Devlin, et al.
The New England Journal of Medicine|February 8, 2024
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging SelectionGregory W Albers, Mouhammad Jumaa, Barbara Purdon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advanced Emergency Nursing Journal|July 30, 2019
Choosing the Correct "-ase" in Acute Ischemic Stroke: Alteplase, Tenecteplase, and ReteplaseGeorge M Dillon, Stacie Stevens, Wendy L Dusenbury, et al.
Journal of Clinical Pharmacology|October 24, 2022
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic StrokeFei Tang, Jurgen Langenhorst, Steve Dang, et al.
Expert Opinion on Drug Safety|February 5, 2019
Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplaseKatleen Wyatt Chester, Megan Corrigan, J Megan Schoeffler, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 24, 2018
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and designSharon D Yeatts, Joseph P Broderick, Anjan Chatterjee, et al.
Stroke|September 9, 2021
Thrombolysis in Mild Stroke: A Comparative Analysis of the PRISMS and MaRISS StudiesNegar Asdaghi, Jose G Romano, Hannah Gardener, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 9, 2022
A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and designGregory W Albers, Bruce Cv Campbell, Maarten G Lansberg, et al.
JAMA|July 13, 2018
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical TrialPooja Khatri, Dawn O Kleindorfer, Thomas Devlin, et al.
The New England Journal of Medicine|February 8, 2024
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging SelectionGregory W Albers, Mouhammad Jumaa, Barbara Purdon, et al.
Pageof 1